Proventil HFA, Ventolin HFA, ProAir HFA (Actual) Questions With Correct Solutions.

Albuterol sulfate brand names - Answer-Proventil HFA Ventolin HFA ProAir HFA Albuterol HFA Therapeutic class - Answer-β2 agonist Albuterol HFA Indications - Answer-asthma, exercise-induced asthma; prophylaxis Albuterol HFA CI/BBW - Answer-hypersensitivity to albuterol or any of its components, including milk proteins, or levalbuterol Albuterol HFA adult dosing - Answer-2 oral inhalations 15 to 30 minutes before exercise Albuterol HFA ADR - Answer-nausea, pharyngitis, nervousness, headache, tremor, tachycardia, bronchitis, and cough Albuterol HFA counseling - Answer-Advise patient on proper inhalation technique using inhalers. Instruct patients to report the need for increased frequency or amounts of drug to provide symptomatic relief. Beclomethasone HFA brand names - Answer-Beclovent, Beconase, Qvar, Vancenase, QNASLBeclomethasone HFA therapeutic class - Answer-Inhaled corticosteroid Beclomethasone HFA indications - Answer-Asthma, Nasal polyp, Rhinitis Beclomethasone HFA CI/BBW - Answer-Hypersensitivity to beclomethasone or any other product component, Status asthmaticus (primary treatment, oral inhaltion), Acute ashma episodes requiring intensive measures (oral inhalation) Beclomethasone HFA adult dosing - Answer-Asthma(previously treated with bronchodilators alone): initial, 40 to 80 mcg twice a day; MAX 320 mcg twice daily. Asthma (previously treated with inhaled corticosteroids): initial, 40 to 160 mcg twice daily; MAX 320 mcg twice daily Beclomethasone HFA ADR - Answer-Common: Headache, Pharyngitis Severe: Secondary hypocortisolism, Cataract, Glaucoma Beclomethasone HFA counseling - Answer-Counsel patient to avoid vaccines during therapy, unless approved by healthcare provider. Advise patients with asthma that drug is only used for prevention and will not stop an asthma attack. Advise patient against sudden discontinuation of drug. Instruct patients using the inhaler to rinse out their mouth with water after each use to prevent localized oral infections. Fluticasone propionate nasal spray - Answer-Cutivate, Flonase, Flovent, Flovent Rotadisk, Flovent HFA, Flovent Diskus Fluticasone propionate nasal spraytherapeutic class - Answer-Nasal corticosteroid Fluticasone propionate nasal spray indications - Answer-Allergic rhinitis, Asthma, Atopic dermatitis, Disorder of skin (corticosteroidresponsive dermatoses), Rhinitis (non-allergic) Fluticasone propionate nasal spray CI/BBW - Answer-Hypersensitivity to any component of the product, hypersensitivity to milk proteins, severe (oral inhalation). Primary treatment of status asthmaticus or other acute episodes of asthma requiring intesnive intervention (oral inhalation) Fluticasone propionate nasal spray adult dosing - Answer-Initial, 2 sprays/nostril daily or 1 spray/nostril twice daily, MAX 2 sprays/nostril/day (200 mcg/day) Fluticasone propionate nasal spray ADR - Answer-Common: Headache, cough, epistaxis. Fluticasone propionate nasal spray counseling - Answer-Advise patient that this drug is not indicated for acute asthma attacks. Report signs/symptoms of adrenal supression or hypercortisolism (weight gain, fatigue, muscle weakness, facial rounding; fragile/thin skin) Fluticasone HFA brand names - Answer-Flovent HFA, Flonase, Cutivate, Flovent Fluticasone HFA therapeutic class - Answer-Inhaled corticosteroid Fluticasone HFA indications - Answer-Allergic rhinitis, Asthma, Rhinitis (non-allergic)Fluticasone HFA CI/BBW - Answer-Hypersensitivity to any component of the product Primary treatment of status asthmaticus or other acute episodes of asthma requiring intensive intervention Severe hypersensitivity to milk proteins " Fluticasone HFA adult dosing - Answer-Allergic Rhintis: NASAL INHALATION, initial, 2 sprays/nostril daily or 1 spray/nostril twice daily, MAX 2 sprays/nostril/day (200 mcg/day) For Asthma: (Aerosol) Initial dose, previous therapy with inhaled bronchodilators alone: 88 mcg via oral inhalation twice daily; MAX 440 mcg twice daily For Nasal Polyp: 200 or 400 mcg INTRANASSALY once or twice a day. For Non-Allergic Rhinits: NASAL INHALATION, initial, 2 sprays/nostril daily or 1 spray/nostril twice daily, MAX 2 sprays/nostril/day (200 mcg/day)" Fluticasone HFA ADR - Answer-Candidiasis of mouth and esophagus, Nausea and vomiting, Osteoporosis, Headache, Cough, Epistaxis, Pharyngitis, Sinusitis, Throat irritation, Upper respiratory infection Fluticasone HFA counseling - Answer-Advise patient that this drug is not indicated for acute asthma attacks. This drug may cause pharyngeal candidiasis, epistaxis, or pharyngitis.Advise patient that symptomatic improvement may not be seen for a few weeks. Report signs/symptoms of systemic corticosteroid effects such as adrenal suppression or hypercortisolism, or signs/symptoms of infection. Caregivers of pediatric patients using inhaled form should monitor for and report decreased growth. Patient should rinse mouth with water and spit following inhalation. Advise patient on proper inhalation technique. Patients using the topical formulation should not use occlusive dressings over application site. Patients using the topical formulation should not apply drug to face, underarms, groin, or diaper area" Levalbuterol brand names - Answer-Xopenex, Xopenex Pediatric Levalbuterol therapeutic class - Answer-Beta 2 Agonist Levalbuterol indications - Answer-Asthma Levalbuterol CI/BBW - Answer-Hypersensitivity to racemic albuterol or levalbuterol products Levalbuterol adult dosing - Answer-Acute asthma exacerbation) 1.25 to 2.5 mg ORAL INHALATION every 20 minutes for 3 doses, then 1.25 to 5 mg every 1 to 4 hours as neededBronchospasm -- 0.63 to 1.25 mg nebulized solution ORAL INHALATION 3 times/day (every 6 to 8 hours) as needed Levalbuterol ADR - Answer-Rash, Diarrhea, Tremor, Asthma, Rhinitis, Viral disease, Accidental injury, Fever Levalbuterol counseling - Answer-Advise patient to immediately withdraw therapy if paradoxical bronchospasm occurs Counsel patient to report any hypersensitivity reactions that occur with administration Side effects may include nervousness, headache, tremor, dizziness, palpitations, tachycardia, and chest pain Instruct patient to immediately report symptoms of asthma deterioration (ie, need for larger or more frequent doses) Advise patient on proper inhalation technique, depending on the delivery device used" Montelukast brand names - Answer-Singulair Montelukast therapeutic class - Answer-leukotriene receptor antagonist Montelukast indications - Answer-Asthma- Treatment and Prophylaxis, Exercise-induced asthma- Prophylaxis, Perennial and seasonal allergic rhinitisMontelukast CI/BBW - Answer-hypersensitivity to montelukast or any ingredient in the formulation Montelukast adult dosing - Answer-Asthma; Treatment and Prophylaxis- 10 mg orally in the evening; Exercise-induced asthma, Prophylaxis- 10 mg ORALLY as a single dose at least 2 hours before exercise, no additional doses should be taken within 24 hours of previous dose Montelukast ADR - Answer-Common: Headache. Serious: Allergic granulomatosis angiitis, Stevens-Johnson syndrome, Toxic epidermal necrolysis; Aggressive behavior, Altered behavior, Suicidal thoughts; hematuria Montelukast counseling - Answer-Advise patient that this drug is not indicated for acute asthma attacks. This drug may cause aggressive behavior, agitation, dream disorder, or hallucinations. Instruct patient to report increased use or frequency of short-acting inhaled bronchodilators. Patients with asthma should take dose in the evening. Advise patient not to discontinue or decrease the dose of other asthma medications unless instructed by a healthcare professional. Montelukast pediatric dosing - Answer-Asthma treatment and allergic rhinitis -- up to 5 yo -- 4 mg daily -- 6-14 yo -- 5 mg daily -- 15 and up -- 10mgexercise induced asthma: -- 6-14 yo -- 5 mg two hours before exercise -- 15 and up -- 10 mg two hours before exercise Omalizumab brand name - Answer-Xolair Omalizumab therapeutic class - Answer-monoclonal antibody Omalizumab indications - Answer-IgE mediated allergic asthma, chronic idiopathic urticaria Omalizumab CI/BBW - Answer-anaphylaxis Omalizumab adult dosing - Answer-idiopathic chronic urticaria: 150 or 300 mg SUBQ every 4 weeks; allergic asthma: 150 to 375 mg SUBQ every 2 or 4 weeks; dosage determined by IgE level before first treatment and body weight; do not administer more than 150 mg into one injection site; do NOT use IgE level for subsequent dose determinations unless treatment has been interrupted for more than 1 year Omalizumab ADR - Answer-Common: Injection site reactions, viral infections, upper respiratory tract infection, sinusitis, headache, pharyngitis Omalizumab counseling - Answer-Seek immediate emergency medical treatment if signs/symptoms of anaphylaxis develop. Symptoms can occur 24 hours or longer after drug administration.Full symptomatic improvement may not be immediate. Advise patient that this drug is not indicated for acute asthma attacks, acute bronchospasm, or status asthmaticus Mometasone nasal spray brand name - Answer-Nasonex